When beginning treatment for epilepsy, patients should be sure to communicate frequently with their treatment teams for the best results.
References:
- National Institute of Neurological Disorders and Stroke. Health Information: Epilepsy and Seizures. Accessed April 11, 2023. https://www.ninds.nih.gov/health-information/disorders/epilepsy-and-seizures#.
- Centers for Disease Control and Prevention. Epilepsy: Epilepsy Data and Statistics. Accessed April 11, 2023. https://www.cdc.gov/epilepsy/data-research/facts-stats/?CDC_AAref_Val=https://www.cdc.gov/epilepsy/data/index.html
- Sirven, JI. Epilepsy: A Spectrum Disorder. Cold Spring Harb Perspect Med. 2015;5:a022848.
- Bonnett LJ, Powell GA, Tudur Smith C, Marson AG. Breakthrough seizures—further analysis of the standard versus new antiepileptic drugs (SANAD) study. PLoS One. 2017;12(12):1–16.
- Koubeissi, MZ, Azar NJ. Epilepsy Board Review: A Comprehensive Guide. Springer Nature; 2017.
- Manjunath R, Paradis PE, Parisé H, et al. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization. Neurology. 2012 Oct;79(18):1908-16. doi:10.1212/WNL.0b013e318271f77e
- Devinsky O, Hesdorffer DC, Thurman DJ, et al. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol. 2016;15(10):1075-1088.
- Devinsky O, Spruill T, Thurman D, et al. Recognizing and preventing epilepsy-related mortality: A call for action. Neurology. 2016;86(8):779-786.
- Hakami T. Neuropharmacology of Antiseizure Drugs. Neuropsychopharmacol Rep. 2021 Sep;41(3):336-351. doi:10.1002/npr2.12196.
All information contained on the Catalystpharma.com website is intended for informational and educational purposes. The information provided on this website is not intended to be a replacement or substitute for professional medical advice. Any information that you have received from Catalystpharma.com should be verified with your licensed healthcare provider. Individuals should never disregard or delay seeking medical advice due to the content of this site.
